Agios Pharmaceuticals, Inc. (AGIO): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$308.18M
Year ended 2019-12-31
2017-12-31: -$314.36M2018-12-31: -$355.31M2019-12-31: -$308.18M-$308.18M
2017-12-31 EBITDA (USD) 2019-12-31
Period endedEBITDAChange YoYSource filing
2019-12-31-$308.18Mn/c2022-02-24, From 2019-01-01
2018-12-31-$355.31Mn/m2021-02-25, From 2018-01-01
2017-12-31-$314.36Mn/a2020-02-19, From 2017-01-01